ReviewClinical & experimental metastasis2026
Extracellular vesicles and immune-glial remodeling in lung cancer brain metastasis: potential intersections with exercise-related myokines.
Review in Clinical & experimental metastasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Lung cancer brain metastasis develops through reciprocal interactions between metastatic tumor cells and a brain-specific vascular, glial, and immune microenvironment. Tumor-derived extracellular vesicles (EVs) can participate in this process by altering blood-brain barrier (BBB) properties, influencing brain-directed distribution, and transferring regulatory cargo to endothelial and myeloid recipient cells. This review integrates direct evidence from non-small cell lung cancer (NSCLC) brain or central nervous system metastasis with related lung cancer EV studies, while distinguishing these findings from cross-cancer mechanistic evidence. We first describe the transition from the BBB to the heterogeneous blood-tumor barrier and distinguish the contributions of astrocytes, resident microglia, recruited monocyte-derived macrophages, and T cells. We then examine how defined EV cargo, including lnc-MMP2-2, LINC00482, miR-21, L1CAM, and miR-374a-5p, affects barrier integrity, myeloid state, or brain-metastatic behavior. Myeloid responses are interpreted according to cellular origin and function rather than by a fixed M1/M2 binary. Exercise-related myokines and exerkines are considered separately as a hypothesis-generating systemic layer that could influence tumor-cell EV production, deliver signals through muscle-derived EVs, or alter recipient-cell responsiveness; none of these routes has yet been established as a causal mechanism in lung cancer brain metastasis. Together, current evidence supports a role for EV-mediated vascular and immune/glial communication in lung cancer brain metastasis, while leaving the contribution of exercise-related signals unresolved.
Indexed as
Identifiers
42891911What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.